Unfortunately, the authors have noted an error in the text regarding the safety findings of gadobenate and gadobutrol. The number of patients reporting adverse events following injection of gadobenate and gadobutrol is correctly reported in the Results section, but in the Discussion section, the sentence should read, 'Both contrast agents were well tolerated, with two and five patients reporting adverse events following injection of gadobenate and gadobutrol, respectively.' (Not '…two and five patients reporting adverse events following injection of gadobutrol and gadobenate, respectively'.)
The authors apologise for their error.
